Modern Approaches to the Diagnosis and Treatment of Carditis in Patients with Rheumatic Diseases in the Southern Region of the Kyrgyz Republic: Evidence Base and Clinical Aspects with Regional Comparison

The article discusses modern methods of diagnosis and treatment of carditis in patients with rheumatic diseases in Osh region, as well as a comparative analysis with other southern regions of Kyrgyzstan. A retrospective analysis of the medical records of 750 patients in the southern regions of Kyrgyzstan with rheumatic diseases complicated by carditis was carried out. In Osh region, there is a high incidence of carditis (27%) among patients with rheumatic diseases, which is associated with advanced diagnostic methods and earlier detection of the disease. The frequency of carditis detection in Batken region is 19%, and in Jalal-Abad region — 22%, which indicates a low frequency of early detection of complications of the disease. The issues of clinical manifestations and differential diagnosis are highlighted. An analysis of the effectiveness of various therapeutic approaches, taking into account regional peculiarities, is presented. The evidence base of the study includes data from retrospective and prospective follow-up, as well as international clinical guidelines. The work is aimed at identifying regional differences in the diagnosis and treatment of carditis, which is important for the development of effective medical care strategies. For example, in the Batken region, it is recommended to improve the diagnostic infrastructure and introduce more modern diagnostic methods, which will help to increase the detection of the disease at an early stage. To improve the quality of diagnosis and treatment, it is necessary to introduce standardized clinical protocols based on international recommendations and ensure equal access to modern therapeutic methods in all regions of Kyrgyzstan. It is important to strengthen professional development programs for medical professionals, improve the availability of specialized cardiorheumatology services, and expand opportunities for innovative treatment methods.